S&P: Express Scripts outlook positive

Standard & Poor's said it revised its outlook on Express Scripts Inc. to positive from stable and affirmed its ratings, including the BBB corporate credit rating.

The agency said the outlook revision reflects its increased confidence in Express Scripts' ability to integrate its Dec. 1, 2009 acquisition of WellPoint's NextRx given that more than 50% of NextRx's members have been transitioned to Express Scripts' information technology systems. S&P also believes that the company will likely meet its 2010 debt maturities and operate with a financial policy consistent with a modest financial risk profile.

In addition, U.S. health-care reform legislation left the PBM business model intact, the agency said; items such as direct drug price negotiations by the government were not enacted.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.